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ative Coronary Disease Progression
xceeds Failed Revascularization as
ause of Angina After Five Years in the Bypass
ngioplasty Revascularization Investigation (BARI)
dwin L. Alderman, MD, FACC,* Kevin E. Kip, PHD,† Patrick L. Whitlow, MD, FACC,‡
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acques Lesperance, MD, Leonard Schwartz, MD, FACC,¶ Michael Stadius, MD, FACC#
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anada; and Seattle, Washington
OBJECTIVES Coronary angiograms obtained five years following revascularization were examined to assess
the extent of compromise in myocardial perfusion due to failure of revascularization versus
progression of native disease.
BACKGROUND The Bypass Angioplasty Revascularization Investigation (BARI) randomized revasculariza-
tion candidates between bypass surgery and angioplasty. Entry and five-year angiograms from
407 of 519 (78%) patients at four centers were analyzed.
METHODS Analysis of the distribution of coronary vessels and stenoses provided a measure of myocardial
jeopardy that correlates with presence of angina. The extent to which initial benefits of
revascularization were undone by failed revascularization versus native disease progression was
assessed.
RESULTS Myocardial jeopardy fell following initial revascularization, from 60% to 17% for percutane-
ous coronary intervention (PCI)-treated patients compared with 60% to 7% for coronary
artery bypass graft (CABG) surgery patients (p  0.001), rebounding at five years to 25% for
PCI and 20% for surgery patients (p  0.01). Correspondingly, angina prevalence was higher
at five years in PCI-treated patients than in surgery-treated patients (28% vs. 18%; p 0.03).
However, myocardial jeopardy at five years, and not initial treatment (PCI vs. surgery), was
independently associated with late angina. Increased myocardial jeopardy from entry to
five-year angiogram occurred in 42% of PCI-treated patients and 51% of CABG-treated
patients (p  0.06). Among the increases in myocardial jeopardy, two-thirds occurred in
previously untreated arteries.
CONCLUSIONS Native coronary disease progression occurred more often than failed revascularization in
both PCI- and CABG-treated patients as a cause of jeopardized myocardium and
angina recurrence. These results support intensive postrevascularization risk-factor
modification. (J Am Coll Cardiol 2004;44:766–74) © 2004 by the American College of
Cardiology Foundationc
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che Bypass Angioplasty Revascularization Investigation
BARI) is a randomized study comparing a revascularization
trategy of initial coronary angioplasty versus coronary
urgery for management of patients with multivessel coro-
See page 775
ary disease. The primary BARI end point was five-year
urvival (1,2). To help understand the relationship of
evascularization procedures to long-term angiographic and
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ania; ‡Cleveland Clinic, Cleveland, Ohio; §Cardiology Division, Duke University,
urham, North Carolina; Montreal Heart Institute, Montreal, Canada; ¶Toronto
eneral Hospital, Toronto, Canada; and #University of Washington, Seattle,
ashington. This project was funded by NHLBI Grant HL51419.
Manuscript received June 30, 2003; revised manuscript received April 23, 2004,accepted May 4, 2004.linical outcome, four BARI clinical sites obtained repeat
oronary angiography five years following study entry. The
oals of the present analysis were to: 1) describe five-year
ngiographic history and outcome of BARI patients with
ultivessel coronary disease treated with initial percutane-
us coronary intervention (PCI) or coronary artery bypass
raft surgery (CABG) and 2) assess the relative impact of
evascularization failure (e.g., restenosis or graft occlusion)
ersus native disease progression on the redevelopment of
schemic symptoms and myocardial jeopardy following re-
ascularization by PCI or by surgery.
ETHODS
he BARI study protocol, including details regarding ob-
ectives, recruitment, inclusion, and exclusion criteria, data
ollection, procedural guidelines, angiographic definitions,
nd participating sites, has previously been published (3).
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August 18, 2004:766–74 Angiographic Results After PCI or CABG in BARIngiographic entry requirements included absence of severe
eft main disease and presence of multiterritory coronary
isease. Patients were accepted as suitable candidates only if
evascularization of clinically important stenoses were fea-
ible by both angioplasty and surgery, as assessed by both
ardiac surgeons and interventional cardiologists. There was
o requirement for equivalent or complete revascularization.
alloon angioplasty was the only percutaneous technique
tilized in BARI, although, at a few sites, stenting was
vailable as a bailout device for threatened closure under a
ood and Drug Administration-approved investigational
rotocol.
atient population. Between August 1988 and July 1991,
total of 1,829 patients from 18 clinical centers were
andomized in BARI. Four clinical sites volunteered to
btain five-year follow-up angiograms on all consenting
ve-year survivors out of the 572 randomized patients at
heir sites. Five-year angiography was accomplished in 407
f 519 surviving patients (78%). The sites were located at
he Montreal Heart Institute (167 patients), Cleveland
linic (107 patients), Duke University (79 patients), and
oronto General Hospital (54 patients). All patients com-
leted five-year angiography within 12 months preceding or
ix months following their five-year anniversary. The mean
ollow-up interval was 5.0 years, with 94% of angiograms
ccomplished between 4.6 to 5.4 years. The presence of
schemic symptoms, use of hypolipidemic medications, and
ncremental hospitalizations were assessed from study entry
o five-year follow-up by nurse-coordinator interviews at the
linical sites. A subset of 183 patients consented to one-year
ollow-up angiography in addition to five-year angiography
4).
ngiographic evaluation—BARI myocardial jeopardy
ndex. Entry and subsequent procedure-related, intercur-
ent, and protocol-mandated one- and five-year angiograms
ere assessed by the Stanford angiography laboratory,
linded as to clinical outcomes. Angiographic data included
dentification of occluded and stenotic (50%) arteries and
ssessment of left ventricle (LV) myocardial jeopardy. The
ercentage of LV myocardium jeopardized by lesions50%
as based on the extent of distribution of the three main
oronary arteries and all major branches. Each vessel was
ized as small, medium, or large based on the vessel’s length
nd extent of branching (Fig. 1) (5). Native coronary artery
Abbreviations and Acronyms
BARI  Bypass Angioplasty Revascularization
Investigation
CABG  coronary artery bypass graft surgery
CHC  Canadian Heart Classification
CI  confidence interval
LV  left ventricle/ventricular
OR  odds ratio
PCI  percutaneous coronary intervention
TIMI  Thrombolysis In Myocardial Infarctionistribution was based on observer grading of the distal
erminating arteries limited to those approximately 1.5
m diameter. Terminating arteries for which size and
erritorial distribution were assigned potentially included
-3 diagonal branches, 0-3 marginal branches, ramus inter-
edius, sub-branches for each of these, septal, posterolat-
ral, posterior descending, and the distal terminations of the
eft anterior descending, circumflex, and right coronary
rteries (Fig. 1).
A numerical score reflecting the size of LV territory
upplied by each vessel was based on the ratio of the length
f the terminating artery to the LV base to apex distance
and to a lesser extent the circumferential spread of smaller
ranches). A numerical LV score for each terminating artery
as assigned based on extent of LV distribution: insignifi-
ant (ratio:1/5; score: 0), small (ratio 1/5 to 1/3; score: 1);
edium (ratio: 1/3 to 2/3; score: 2), and large (ratio: 2/3;
core: 3;). The sum of scores for all terminal arteries reflects
he coronary distribution to the entire LV myocardial
erritory. Regional myocardial jeopardy (anterior, inferior,
nd lateral) was computed as the ratio of units of anatom-
cally relevant vessels containing a50% stenosis to the sum
f regional coronary territory scores.
The total units of myocardial territory per patient ranged
rom 8 to 38 (mean and median: 24), and the number of
yocardial territory units jeopardized at study entry ranged
rom 3 to 27 (mean and median: 15). Entry myocardial
eopardy in this study ranged from 15% to 100% (mean and
edian: 60%). Coronary grafts not compromised by  50%
tenosis were considered to relieve myocardial jeopardy in
he grafted native vessel and its branches in both the
nterograde and retrograde directions until encountering a
50% stenosis. Successful PCI (50% residual stenosis and
hrombolysis In Myocardial Infarction [TIMI] flow grade
), was considered to alleviate jeopardy distal to the treated
tenosis.
An anatomically correct computer representation of na-
ive coronary vessel distribution combined with accurate
lacement of stenoses, graft insertions, and PCI results on a
raphic “map” provided the basis for computer summation
f global and regional myocardial jeopardies (5). Regions of
rior myocardial infarction and wall-motion abnormalities
ere not excluded from the calculation of myocardial
eopardy so as to avoid assumptions of territory viability.
linded recycling of 70 angiograms to assess reproducibility
f myocardial jeopardy score yielded an intraclass correlation
oefficient of 0.77 between duplicate readings (5), thereby
ndicating excellent reproducibility (6).
A caliper with electronic data output was used to measure
tenosis minimum and reference diameters in a single-plane
rojection that adequately visualized maximum narrowing
7). Progression of preexisting disease and new disease
equired “visually unequivocal change.” This definition was
mplemented in order to prevent minor numeric changes in
aliper measurements that crossed a 50% stenosis threshold
rom having undue effects. Successful revascularization after
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Angiographic Results After PCI or CABG in BARI August 18, 2004:766–74n angioplasty required a residual stenosis of 50%, 20%
hange, and TIMI flow grade 3. At the five-year evaluation,
uccess required 50% stenosis.
Both global and regional myocardial jeopardy were as-
essed on all entry, intercurrent, or postangioplasty and
ve-year angiograms. Immediate post-CABG myocardial
eopardy was assessed, assuming that all grafts placed during
urgery are initially patent. Comparisons with preceding
ngiograms were performed using dual projectors to identify
ew stenoses exceeding 50% and to note changes in previ-
usly observed lesions.
Myocardial jeopardy observed on the final five-year angio-
ram was attributed to the most proximate cause. Thus,
yocardium, jeopardized by a stenosis initially relieved by a
uccessful PCI procedure, but jeopardized by restenosis at
ve-year angiography, is considered a revascularization failure.
graft occlusion or stenosis 50% in a graft is considered a
evascularization failure. A new stenosis appearing distal to a
raft insertion, or a new 50% native vessel stenosis observed
n the five-year angiogram, each adds to myocardial jeopardy
epending upon the amount of territory involved.
tatistical analysis. Baseline clinical and angiographic
haracteristics were compared between patients who had
ve-year angiography and both surviving and nonsurviving
ubsets of patients without five-year angiography by use of
hi-square tests for categorical variables and Wilcoxon tests
igure 1. The coronary artery map used by Bypass Angioplasty Revasculari
tenosis placement, and estimation of myocardial jeopardy. The map is a mo
f additional branch segments.or continuous variables. Five-year rates of repeat revascu- uarization were calculated, irrespective of whether or not
CI or CABG was performed as the first repeat procedure,
nd whether or not the first repeat procedure occurred
ithin the initial six months of follow-up. These analyses
ere restricted to the 402 five-year angiography patients
PCI 202; CABG 200) who underwent their randomly
ssigned treatment (per protocol analysis). Risk-factor status
smoking history, aspirin use, lipid-lowering drug use) was
lso assessed at baseline and at five-year follow-up owing to
ts potential influence on long-term disease progression.
Logistic regression analysis was used for two purposes:
) estimate risk of angina at five years in relation to
aseline clinical and angiographic characteristics, includ-
ng myocardial jeopardy; and 2) estimate impact of use of
ipid-lowering drugs at study entry and during the first
wo years of follow-up on risk of increased jeopardized
yocardium at the five-year angiographic assessment.
omparisons of myocardial jeopardy (at study entry,
ostinitial revascularization, and at five-year follow-up)
verall, and within individual myocardial territories, were
ade between PCI- and CABG-treated patients by use
f Student t tests. Within treatments, paired t tests were
sed to compare myocardial jeopardy at entry and five-
ear follow-up. Comparisons of causes of increased jeop-
rdy at five years (i.e., revascularization failure vs. disease
rogression) and specific vessels (initially treated vs.
Investigations (BARI and BARI2D) is the basis for relative artery sizing,
tion of the Coronary Artery Surgery Study (CASS) diagram with inclusionzation
dificantreated) with increased jeopardy were compared be-
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August 18, 2004:766–74 Angiographic Results After PCI or CABG in BARIween PCI- and CABG-treated patients by use of
he Fisher’s exact test. Any p values below 0.05 were
onsidered statistically significant. Owing to the descrip-
ive nature of this analysis (rather than hypothesis-
onfirming), no corrections were made for the multiple
tatistical tests performed.
ESULTS
atient features of full BARI cohort. The 407 patients
ho had five-year angiography presented with a different
nd overall less severe clinical profile at study entry than the
ther five-year surviving and nonsurviving BARI patients
Table 1). Specifically, among survivors at the four protocol
ngiography sites, those who had angiographic evaluation at
ve years were younger (59  9 vs. 61  10 years; p 
.01), and less likely to be female (25% vs. 43%; p 
.0004), a current smoker (26% vs. 39%; p  0.006), have
history of congestive heart failure (2% vs. 8%; p  0.006),
nd have an ejection fraction 50% (15% vs. 28%; p 
.009) than were patients without five-year angiography.
imilar differences were observed comparing the 407 pa-
ients who had five-year angiography and the five-year
urviving patients at nonprotocol angiography sites. Com-
aring the five-year angiography patients with nonsurvivors
t all sites indicated younger age (59  9 vs. 65  9 years),
ess frequent history of congestive heart failure (2% vs. 26%),
able 1. Comparison of Clinical and Angiographic Characteristic
Patient Characteristics
5-Yr Surv
Angi
Patients With
5-Yr Angiograph
(n  407)
ntry features—clinical
Age (mean  SD) 59 (9)
Women 25%
Aspirin use 71%
Lipid-lowering drug 9%
Current smoker 26%
Prior MI 50%
History of CHF 2%
Severe angina at study entry* 75%
Treated diabetes 12%
ntry features—angiographic
Three-vessel disease 34%
Lesions 50% (mean  SD) 3.3 (1.4)
One or more 100% lesions 28%
Ejection fraction 50% 15%
Percent myocardium jeopardized (mean  SD) 60 (16)
Randomly assigned to PCI (vs. CABG) 50%
isk factor control at 5 yrs
Aspirin use 87%
Lipid-lowering drug 44%
Current smoker 22%
Canadian Heart Classification, (CHC) 3, 4, or unstable angina. Missing cases: les
eopardized (n 4); lipid-lowering drug (n 2); history of myocardial infarction (MI)
raction (n  475).
BARI  Bypass Angioplasty Revascularization Investigation; CABG  coronaryess treated diabetes (12% vs. 42%), fewer stenoses 50% at (tudy entry (3.3  1.4 vs. 3.8  1.6), and less prevalent
jection fraction 50% (15% vs. 37%) (p  0.0001 for all
omparisons). Thus, the five-year angiography patients had
he least severe clinical profile at study entry, the other
ARI-surviving patients were intermediate in terms of risk,
nd patients who did not survive to five years had the most
evere clinical and angiographic presentation.
At study entry, aspirin use was frequent among the four
atient groups (71% to 77%); the prevalence of current
moking was modest (22% to 39%), and use of lipid-
owering drugs was infrequent (9% to 13%). Among the
ve-year survivors, aspirin use increased (used in 84% to
8% of all patients), and the use of lipid-lowering drugs
ncreased by approximately 4-fold, yet remained below 50%
36% to 44% of all patients). The prevalence of smoking was
ssentially unchanged from study entry to five years among
atients who underwent five-year angiography (26% vs.
2%). In contrast, smoking decreased markedly from study
ntry to five years in the other surviving patients at both
rotocol (39% to 14%) and nonprotocol (24% to 11%)
ngiography sites.
nitial and intercurrent revascularization of patients who
nderwent five-year angiography. The 202 PCI-treated
atients who subsequently underwent five-year angiography
ad a mean of 3.2 lesions of 50% severity at study entry,
f which, 2.6 lesions were attempted on the initial PCI
5-Year Angiography Patients and Other BARI Patients
at Protocol
hy Sites All Other BARI Patients
Patients Without
5-Yr Angiography
(n  112)
5-Yr Surviving
Patients
(n  1,087)
Patients Not Surviving
to 5 Yrs
(n  223)
61 (10) 62 (9) 65 (9)
43% 25% 28%
73% 77% 73%
13% 12% 10%
39% 24% 22%
60% 55% 58%
8% 8% 26%
76% 80% 82%
18% 18% 42%
42% 43% 46%
3.5 (1.4) 3.5 (1.3) 3.8 (1.6)
31% 40% 41%
28% 22% 37%
61 (16) 62 (17) 63 (17)
50% 49% 56%
88% 84% —
36% 36% —
14% 11% —
50% stenosis (n  3); 1 or more 100% lesions (n  3); percentage myocardium
8); history of congestive heart failure (CHF) (n 10); vessel disease (n 3); ejection
bypass graft surgery; PCI  percutaneous coronary intervention.s of
ivors
ograp
y
ions 
(n 1total 522 lesions) (Table 2). At the initial procedure, 65%
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Angiographic Results After PCI or CABG in BARI August 18, 2004:766–74f PCI patients had all attempted lesions successfully dilated
50% residual stenosis and TIMI flow grade 3), an
dditional 29% had 1 attempted lesion successfully di-
ated, and the remaining 6% had no lesions successfully
ilated. On a lesion level, 412 of 485 attempted lesions
85%) with initial stenosis 50% were successfully dilated
Table 2). The 200 coronary surgery patients had a mean of
.3 stenoses, with an average of 2.9 distal graft anastomoses
er patient. A total of 198 internal mammary artery grafts
nd 334 saphenous vein grafts were placed at the initial
urgery.
The higher mean number of stenoses treated in surgery
atients than in PCI-treated patients was reflected in more
requent initial revascularization in both the left anterior
escending artery (90% vs. 77%; p  0.0005) and left
ircumflex and/or right coronary artery (99% vs. 86%; p 
.0001) (Table 2). Similarly, separate consideration of the
nterior, lateral, and inferior territories showed that the
nitial CABG procedure was significantly better than the
nitial PCI procedure for immediate improvement of jeop-
rdy in all three territories (data not shown). Thus, the
ean percentage of remaining myocardium jeopardized
fter initial revascularization was lower in surgery than in
CI patients (7% vs. 17%; p  0.0001), as was the mean
ercentage of initial myocardial jeopardy remaining uncor-
ected (11% vs. 28%; p  0.0001).
Fifty-three percent of PCI-treated patients had repeat
evascularization within five years compared to only 8% of
urgery-treated patients (Table 2). Among initial PCI-
Table 2. Initial and Intercurrent Revascularizat
Initial revascularization
Vein grafts (CABG)
LIMA grafts (CABG)
Stenoses attempted (PCI)
Stenoses 50% attempted (PCI)
Stenoses 50% successfully treated
LAD revascularization*
LCx/RCA revascularization*
Mean % of myocardium remaining jeopardized aft
revascularization*
Mean % of initial myocardial jeopardy remaining
uncorrected*
Intercurrent revascularization
No repeat revascularization*†
PCI without CABG
PCI within 6 months of randomization
PCI beyond 6 months of randomization
PCI first with subsequent CABG
CABG as first repeat revascularization
CABG at any time
*p  0.001 for comparison of PCI- and CABG-assigned pa
statistically different (p  0.001) between PCI and CABG
five-year angiography study.
LAD  left anterior descending coronary artery; LCx 
artery; RCA  right coronary artery; other abbreviations asreated patients, 20% had bypass surgery during follow-up. pngiographic evaluation at five years. Five-year angiog-
aphy showed that of 412 successfully treated significant
esions, 61% had no interval restenosis, an additional 23%
emained successful after interval retreatment, and the
emaining 16% remained stenotic as a result of no retreat-
ent or failed retreatment (Table 3). Of 334 vein grafts
laced during the initial surgery, 16% had a 50% stenosis
t five years and 13% were totally occluded (Table 3). Of
98 internal mammary artery grafts placed during the
nitial procedure, 11% had a stenosis or vessel kink
50%, and 5% were totally occluded at five years. The
23 distal anastomoses to the left anterior descending
rtery (left internal mammary artery: 198; vein grafts: 25)
ere more likely to be patent and free of significant
tenoses at five years (91%) than were the 320 distal
nastomoses to other vessels (82%).
On a patient level, myocardial jeopardy remained lower at
ve years for patients initially having surgery compared with
hose treated with PCI (surgery: 20% vs. PCI: 25%; p 
.01) despite 53% of PCI-treated patients having additional
evascularization procedures versus 8% of CABG-treated
atients (Table 3). However, taking into account the more
xtensive initial revascularization performed in surgery pa-
ients, the mean change in myocardial jeopardy from post-
nitial revascularization to five-year assessment was actually
igher in patients initially treated with surgery than in
CI-treated patients (13% vs. 8%; p  0.03). This reflected
mix of graft failures, new disease, and few incremental
y Randomization Assignment
Assigned to
PCI
(n  202)
Assigned to
CABG
(n  200)
— 334
— 198
522 —
485 —
412 (85%) —
77% 90%
86% 99%
tial 17  19 7  11
28  30 11  16
47% 92%
33% 7%
18% 1%
14% 6%
6% 0%
14% 0%
20% 0%
†The incidence of any type of repeat revascularization was
nts irrespective of whether or not they participated in the
ircumflex coronary artery; LIMA  left internal mammary
le 1.ion b
er ini
tients.
patie
left crocedures in surgery-treated patients. At five years, only
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August 18, 2004:766–74 Angiographic Results After PCI or CABG in BARIhe anterior territory retained a significantly lower jeopardy
fter CABG compared with PCI (Table 3).
Among the subset of 183 patients who underwent both
ne- and five-year angiography, the majority of angio-
raphic benefit achieved (reduced jeopardized myocardium)
as retained between years one and five of follow-up (Fig.
A). Importantly, the relationship between angina and
yocardial jeopardy is evident in the subset of 183 BARI
atients who had baseline and both protocol-directed one-
ear and five-year angiography (Fig. 2B).
ngina at five-year follow-up and relationship to myo-
ardial jeopardy. The proportion of five-year angiography
atients with any angina, including unstable angina, fell
rom 96% at entry to 23% at five-year clinical follow-up. At
ve years, 28% of the 202 patients initially treated with PCI
ad angina compared with 18% of the 200 surgery-treated
atients (p  0.03). For PCI-treated patients, the preva-
ence of angina at five years was 21% for patients who had
subsequent coronary surgery, 22% for patients who had no
ncremental revascularization procedures, and 38% for pa-
ients who had intercurrent PCI without additional coro-
ary surgery.
By logistic regression analysis, factors independently pre-
ictive of angina at five years included five-year myocardial
eopardy (odds ratio [OR], 1.22 per 10% increase, 95%
onfidence interval [CI], 1.09 to 1.36), severe angina at
ntry (OR, 2.20, 95% CI, 1.17 to 4.14), and ever a smoker
t study entry (OR, 1.91, 95% CI, 1.09 to 3.35; Table 4).
hus, for each 10% increase in myocardial jeopardy at
ollow-up, the estimated odds of having angina increased by
2%. The heightened risk of angina at five years associated
ith greater myocardial jeopardy was similar between PCI-
nd surgery-treated patients.
auses of increased myocardial jeopardy over time. Fig-
Table 3. Angiographic Evaluation at 5 Years b
Angiographic Measurements
Revascularization: lesion-level analysis
PCI—no interval stenosis  50% (n  412)*
PCI—interval stenosis successfully treated
PCI—interval stenosis not treated or failed retreat
Vein graft  50% stenosis (n  334)
Vein graft 100% stenosis
LIMA graft  50% stenosis (n  198)
LIMA graft 100% stenosis
Myocardial jeopardy: patient-level analysis
Mean % of myocardium jeopardized
Global—all territories†
Anterior territory‡
Lateral territory
Inferior territory
Change in % myocardium jeopardized between po
revascularization and 5-yr assessment†
*Includes the 412 of 485 significant lesions ( 50% stenosi
Thrombolysis In Myocardial Infarction 3) at the initial PCI
Abbreviations as in Tables 1 and 2.re 3 shows the proximate cause of any increase in myocar- fial jeopardy from that assessed after completion of the
nitial revascularization procedure (PCI or CABG) to the
ve-year angiogram. This analysis considers only myocar-
ial jeopardy present on the five-year angiogram that had
ot been mitigated by additional intercurrent revasculariza-
ion procedures, and it identifies whether disease progres-
ion or revascularization failure most immediately preceded
he final angiogram. Thus, individual patients could have
isease progression and/or revascularization failure contrib-
ting to five-year myocardial jeopardy.
Myocardial jeopardy increases at five years were frequent
nd modestly more likely to occur in surgery- than in
CI-treated patients (51% vs. 42%; p 0.06) (Fig. 3). This
odest difference was principally due to more disease
rogression in surgery patients (40% vs. 30%; p  0.05), as
ates of increased jeopardy due to revascularization failure
ere similar by initial mode of revascularization (22% vs.
0%; p 0.62, respectively). Overall, 9% of all patients who
nderwent five-year angiography showed evidence of in-
reased jeopardy due to both revascularization failure and
isease progression.
Figure 4 shows the distribution of sources of increased
eopardized myocardium among the subset of 158 patients
ho showed evidence of new or progressive disease on the
ve-year angiogram. Among PCI-treated patients, new or
rogressive disease was most likely to occur in untreated
essels only (65%) compared to initial treated vessels only
20%) and both treated and untreated vessels (14%). Similar
esults were observed among surgery patients (55% vs. 27%
s. 18%, respectively). Thus, coronary disease progression
as more commonly seen in artery locations that, at study
ntry, had not been the target of the initial interventions.
elation of lipid control and disease progression during
ollow-up. Use of lipid-lowering drugs increased sharply
ndomization Assignment
Assigned to PCI
(n  202)
Assigned to CABG
(n  200)
61% —
23% —
16% —
— 16%
— 13%
— 11%
5%
25  22 20  20
23  33 14  22
22  33 21  30
33  44 29  40
tial 8  25 13  17
were attempted and successfully treated ( 50% stenosis,
0.05. ‡p  0.01.y Ra
ment
st-ini
s) that
. †p rom baseline to five-year follow-up (from 9% to 44%), yet they
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Table 1). Eight percent of patients (32 of 398) reported use of
ypolipid medications at both study entry and during two-year
ollow-up; 29% (115 of 398 patients) reported being nonusers
t study entry while becoming first users during the initial two
ears of follow-up; and the remaining 63% (251 of 398
atients) reported being nonusers both at entry and during
wo-year follow-up. Compared to consistent nonusers of hy-
olipid medications, logistic regression analyses (with adjust-
Table 4. Logistic Regression Analysis of Entry C
Angina at 5 Years (n  401 Patients Who Unde
Entry Feature
Angiographic (continuous variable)
Myocardial jeopardy at 5 yrs (per 10% increase)
Clinical (discrete variable)
Severe angina at entry (CHC 3, 4, or unstable ang
Current or former smoker at baseline
Other variables considered include age, gender, initial mode o
lesion, number of significant lesions, history of diabetes, MI,
five years, percentage of disease progression at five years. In a
or CABG), the interaction effect between mode of revascula
not statistically significant (p  0.51).
igure 2. (A) The distribution of myocardial jeopardy scores at baseline, on
ssessments. The center block on each vertical line depicts the mean my
epresent myocardial jeopardy scores at  1 SD from the mean. The “n
ndergone prior coronary artery bypass graft surgery (CABG) at each foll
aseline, one-year, and five-year angiography by assigned mode of initialAbbreviations as in Table 1.ent for age, gender, entry myocardial jeopardy, type of
evascularization, and smoking status) showed that hypolipid
edication users at study entry, but not those who became first
sers during two-year follow-up, had a significantly lower
djusted odds of increased myocardial jeopardy during
ollow-up (OR, 0.38, 95% CI, 0.16 to 0.89; OR, 1.11, 95% CI,
.70 to 1.75, respectively). When the cause of increased
yocardial jeopardy was limited to revascularization failure,
here was a nonsignificant suggestion that use of hypolipid
al and Angiographic Features Associated With
t Their Randomly Assigned Treatment)
Odds Ratio
95% Confidence
Interval p Value
1.22 1.09–1.36 0.0003
2.20 1.17–4.14 0.01
1.91 1.09–3.35 0.02
cularization (PCI or CABG), totally occluded lesion, diffuse
F, regular exercise at baseline, percentage of new disease at
te model that included initial mode of revascularization (PCI
n and percentage jeopardized myocardium at five years was
, and five-year angiography among the subset of 183 patients with all three
ial jeopardy; the horizontal hash marks at each end of the vertical line
the percutaneous coronary intervention (PCI) group reflect not having
assessment. (B) Histogram of the percentage of patients with angina at
ularization (CABG or PCI).linic
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onferred preferential benefit (baseline use: OR, 0.43, 95% CI,
.14 to 1.30; follow-up use: OR, 0.61, 95% CI, 0.34 to 1.09).
ISCUSSION
elationship of angina to myocardial jeopardy. The goal
f this study was to evaluate the extent to which failure of
evascularization or disease progression accounted for myo-
ardial jeopardy and associated angina five years after a
atient’s initial revascularization procedure. The index of
V myocardial jeopardy that was used as a correlate of
schemic symptoms is supported by the strong association
etween five-year angiographic assessment of global myo-
ardial jeopardy and the prevalence of angina that was
bserved for both PCI- and CABG-treated patients (Table
). Moreover, a close temporal relationship existed between
igure 3. Percentage of patients with increased jeopardized myocardium at
ve years, including cause of increased jeopardy and assigned mode of
nitial revascularization. Some patients have multiple causes of increased
yocardial jeopardy, and thus are included in multiple categories. Open
ars  percutaneous coronary intervention patients (202); solid bars 
oronary artery bypass graft surgery patients (200). *Defined as increased
eopardy that occurs after initial revascularization and is not mitigated by
ubsequent revascularization procedures.
igure 4. Among patients with new or progressive disease evident at five
ears, histogram shows the percentage of all patients who experienced
ncreased myocardial jeopardy attributable to vessels treated and/or un-
reated at the initial revascularization procedure. Open bars  percutane-
us coronary intervention patients (76); solid bars coronary artery bypass
raft surgery patients (82).yocardial jeopardy score and angina in the subset of study
atients who had one-year angiography despite not factor-
ng in the viability of the perfused myocardium (Fig. 2).
The BARI myocardial jeopardy index used in this study
5) was developed to correlate with ischemic symptoms by
ncluding smaller LV myocardial subdivisions than prior
lgorithms (based on coronary branch vessel distribution)
nd choice of a 50% rather than a 70% threshold, which is
omewhat better correlated with survival (8). The threshold
sed in this study to define myocardial jeopardy reflects
urrent practice patterns that use a 50% threshold to identify
schemia-provoking revascularization targets. However, this
hreshold of a 50% reduction in lumen diameter does not
ccount for the effects of arterial remodeling and disease
rogression in adjacent comparator vessel segments.
In addition to myocardial jeopardy, severe angina and
rior smoking history at study entry were independently
ssociated with angina at five years. Although initial or
ubsequent bypass surgery was suggestive of lower myocar-
ial jeopardy at five years compared to treatment with PCI
lone, only myocardial jeopardy was independently associ-
ted with angina at five years. These data support use of
yocardial jeopardy as a surrogate of ischemia, irrespective
f whether PCI and/or bypass surgery was performed.
In our study, diabetes was not predictive of increased
yocardial jeopardy, a finding that may reflect early mor-
ality reducing representation of diabetic patients. Patients
aving protocol-directed angiography in this five-year
ollow-up study had less adverse clinical and angiographic
rofiles than all other surviving and nonsurviving BARI
atients. Despite this limitation, this cohort of subjects
epresents a consecutive series of randomized patients (sur-
ivors) at four participating clinical centers. During five
ears of follow-up post-PCI, angiographic restenosis was
bserved in 39% of initial successfully treated lesions, of
hich the majority were successfully retreated by angio-
lasty alone. Slightly more then half of all angioplasty
atients required additional revascularization within five
ears, and 20% of these patients underwent bypass surgery.
imitations of serial angiography to assess the role of
isease progression versus revascularization failure on
schemic outcomes. A five-year angiogram alone cannot
dentify on a lesion-by-lesion basis the final cause of LV
eopardy without considering the intervening sequence of
evascularization successes and failures, additional revascu-
arization procedures, and native vessel changes revealed by
linically indicated angiograms. This study, therefore, uses a
essel-by-vessel analysis that accepts intercurrent revascu-
arizations and their failures as normal clinical practice, and
ttributes causes of incremental five-year jeopardy to
hanges revealed on the most immediately relevant angio-
rams. Revascularization events and coronary disease pro-
ression occur at different times and in different vascular
ocations, which combine to yield a net measurement of
ve-year myocardial jeopardy and its causes.
Our results are based on five-year survivors who, follow-
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ngiographic assessment. The net effect of these selection
riteria is not clear. Presumably, the overall less severe
linical and angiographic profile at study entry in the
ve-year angiography patients may have restricted the range
f native vessel disease progression and revascularization
ailure that truly occurred in the BARI cohort at large. This
ncertainty should be kept in mind when interpreting the
esults of this study.
The rates of additional procedures in this BARI study are
imilar to historical rates reported for multivessel disease
atients having bypass surgery or angioplasty. However,
ailure rates for coronary surgery and PCI procedures have
ropped substantially since 1988–1991 when BARI pa-
ients received their initial revascularization, reflecting mul-
iple procedural and pharmacologic advances (stents, arterial
rafts, and coagulation inhibitors). In past angiographic
ollow-up studies, progression of disease in coronary vessels
ot requiring revascularization was observed in up to 32% of
essels and 65% of patients (9).
Coronary disease progression can undo the benefits of
evascularization. Five-year angiography in the Coronary
rtery Surgery Study (CASS) (10,11) reported disease
rogression in 4.3% of normal segments and 18.6% of
reviously diseased segments with diabetes noted as predic-
ive of disease progression. Risk-factor modification has
emonstrable clinical and angiographic benefit from cur-
ently prescribed intensive low density lipoprotein
holesterol-lowering strategy. The post-CABG study’s ag-
ressive lipid-lowering strategy reduced the number of
atients with graft occlusion from 19% to 12% (p  0.001)
ompared with moderate hypolipidemic treatment at 4.3
ears mean angiographic follow-up (12).
The extent to which new or progressing native vessel
isease exceeds that of failed revascularization as the cause
f increasing myocardial jeopardy in this comparison of
CI- and surgery-treated patients is not easily extrapolated
o current revascularization strategies. Initial PCI and op-
rative procedures in BARI (1988 to 1991) antedate current
enefits of drug and nondrug-eluting stents, use of platelet
Ib/IIIa inhibitors, and placement of single or multiple
rterial grafts, all of which improve procedural outcomes.
urrent guidelines for lifestyle change and use of hypolipi-
emic drugs are more aggressive than in the BARI study,
uring which time less than half of all patients were taking
ypolipidemic medication. Intensive risk-factor modifica-
ion and hypolipid medication use slows atherosclerosis
rogression within native coronary arteries of both PCI-
nd CABG-treated patients and may to a lesser extent
mprove long-term patency of both PCI-treated segmentsnd surgical conduits. The potential for disease progression
o undo the benefits of revascularization is evident in this
tudy and supports vigorous risk-factor reduction for pa-
ients having revascularization procedures.
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